miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas

作者: M. Braoudaki , G. I. Lambrou , K. Giannikou , S. A. Papadodima , A. Lykoudi

DOI: 10.1007/S13277-016-4903-7

关键词: Case-control studyBiologyGene expression profilingPathologyAstrocytomaMalignancyReal-time polymerase chain reactionBrain tumormicroRNAEpendymoma

摘要: In the current setting, we attempted to verify and validate miRNA candidates relevant pediatric primary brain tumor progression outcome, in order provide data regarding identification of novel prognostic biomarkers. Overall, 26 resected tumors were studied from children diagnosed with pilocytic astrocytomas (PAs) (n = 19) ependymomas (EPs) (n = 7). As controls, deceased who underwent autopsy not present any malignancy used. The experimental approach included microarrays covering 1211 miRNAs. Quantitative real-time polymerase chain reaction (qRT-PCR) was performed expression profiles miR-15a miR-24-1. multiparameter analyses MATLAB. Matching differentially expressed miRNAs detected both PAs EPs, following distinct comparisons control cohort; however, several cases, they exhibited tissue-specific profiles. On correlations between EP or miR-24-1 found upregulated relapsed cases when compared clinical remission survivors, respectively. Taken together, associations diverse parameters, study repeatedly highlighted as candidate oncogenic molecules associated inferior prognosis ependymoma.

参考文章(43)
Ettore Luzi, Francesca Marini, Isabella Tognarini, Gianna Galli, Alberto Falchetti, Maria Luisa Brandi, The regulatory network menin-microRNA 26a as a possible target for RNA-based therapy of bone diseases. Nucleic Acid Therapeutics. ,vol. 22, pp. 103- 108 ,(2012) , 10.1089/NAT.2012.0344
Jing-Ming Dong, Liang Yan, Jian Zhang, Xu Tian, Qiang Guo, MiRNA-15a inhibits proliferation, migration and invasion by targeting TNFAIP1 in human osteosarcoma cells. International Journal of Clinical and Experimental Pathology. ,vol. 8, pp. 6442- 6449 ,(2015)
Florence L. M. de Groen, Lisette M. Timmer, Renee X. Menezes, Begona Diosdado, Erik Hooijberg, Gerrit A. Meijer, Renske D. M. Steenbergen, Beatriz Carvalho, Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression PLOS ONE. ,vol. 10, pp. e0132495- ,(2015) , 10.1371/JOURNAL.PONE.0132495
Enyu Huang, Ronghua Liu, Yiwei Chu, miRNA-15a/16: as tumor suppressors and more Future Oncology. ,vol. 11, pp. 2351- 2363 ,(2015) , 10.2217/FON.15.101
Alexandra Lycoudi, Danai Mavreli, Ariadni Mavrou, Nikolas Papantoniou, Aggeliki Kolialexi, miRNAs in pregnancy-related complications Expert Review of Molecular Diagnostics. ,vol. 15, pp. 999- 1010 ,(2015) , 10.1586/14737159.2015.1053468
P. Fallah, N. Amirizadeh, B. Poopak, G. Toogeh, E. Arefian, F. Kohram, S. M. A. Hosseini Rad, M. Kohram, H. Teimori Naghadeh, M. Soleimani, Expression pattern of key microRNAs in patients with newly diagnosed chronic myeloid leukemia in chronic phase. International Journal of Laboratory Hematology. ,vol. 37, pp. 560- 568 ,(2015) , 10.1111/IJLH.12351
Prasun J. Mishra, Bo Song, Pravin J. Mishra, Yuan Wang, Rita Humeniuk, Debabrata Banerjee, Glenn Merlino, Jingfang Ju, Joseph R. Bertino, MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism PLoS ONE. ,vol. 4, pp. e8445- ,(2009) , 10.1371/JOURNAL.PONE.0008445
B. Zhang, S. Kirov, J. Snoddy, WebGestalt: an integrated system for exploring gene sets in various biological contexts Nucleic Acids Research. ,vol. 33, pp. 741- 748 ,(2005) , 10.1093/NAR/GKI475
Guoqi Song, Ling Gu, Junhong Li, Zhipeng Tang, Hong Liu, Baoan Chen, Xuemei Sun, Bangsun He, Yuqin Pan, Shukui Wang, William C. Cho, Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients. Annals of Hematology. ,vol. 93, pp. 1735- 1743 ,(2014) , 10.1007/S00277-014-2111-3
QIFENG LUO, XIAOYU LI, JIA LI, XIANGJIE KONG, JUNFENG ZHANG, LEI CHEN, YIXIANG HUANG, LIN FANG, MiR-15a is underexpressed and inhibits the cell cycle by targeting CCNE1 in breast cancer International Journal of Oncology. ,vol. 43, pp. 1212- 1218 ,(2013) , 10.3892/IJO.2013.2034